Patents by Inventor Benjamin R. Brozanski

Benjamin R. Brozanski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210205163
    Abstract: The present invention relates to a joint positioning device for positioning a joint and methods for using such devices. The joint positioning device may comprise a patient support comprising a substantially flat surface, the patient support configured to be positioned on a medical examination table; a first leg and a second leg extending from the patient support, the legs configured to immobilize the patient support to the medical examination table in a lateral or longitudinal direction. The joint positioning device may further comprise a vertical pillar or pole, the vertical pillar or pole oriented substantially perpendicular to the substantially flat surface of the patient support, the vertical pillar or vertical pole extending in an opposite direction from the first leg and the second leg.
    Type: Application
    Filed: September 23, 2019
    Publication date: July 8, 2021
    Inventors: Sean McMillan, Alfred J. Intintoli, Benjamin R. Brozanski
  • Publication number: 20210170075
    Abstract: Various embodiments relate to catheter locking solutions and catheter locking therapies with use of trisodium citrate and ethyl alcohol, and in particular 4.0 to 15.0 weight/volume % trisodium citrate as an anticoagulant component and/or an antibacterial component and 15.0 to 25.0 volume/volume % ethyl alcohol as an antibacterial component. Use of the catheter locking solution and catheter locking therapy can reduce treatment failure during medical procedures that may employ catheters to supply treatment by at least significantly reducing the risks associated with bloodstream infections, catheter system malfunction, emboli formation, patient discomfort, and patient illness. These benefits can be partially due to the synergistic antibacterial effects of the trisodium citrate and ethyl alcohol in solution, generating an effective catheter locking solution with minimal concentrations of ethyl alcohol.
    Type: Application
    Filed: February 18, 2021
    Publication date: June 10, 2021
    Inventors: Premkumar Babu, Benjamin R. Brozanski, Lisa Pagano, Jeffrey S. Bennett
  • Publication number: 20210113408
    Abstract: The present invention related to a joint positioning device for positioning a joint and methods for using such devices. The joint positioning device may comprise a patient support comprising a substantially flat surface, the patient support configured to be positioned proximate to a chair; a shoulder pole mounted to the patient support, the shoulder pole oriented substantially perpendicular to a substantially flat surface of the patient support; and a cylindrical shoulder pad mounted to the shoulder pole, the shoulder pad oriented substantially perpendicular to the shoulder pole. The joint positioning device may further comprise a vertical pillar, the vertical pillar oriented substantially perpendicular to the substantially flat surface of the patient support.
    Type: Application
    Filed: October 8, 2020
    Publication date: April 22, 2021
    Inventors: Joseph A. Abboud, Alfred J. Intintoli, Benjamin R. Brozanski
  • Patent number: 10940240
    Abstract: Various embodiments relate to catheter locking solutions and catheter locking therapies with use of trisodium citrate and ethyl alcohol, and in particular 4.0 to 15.0 weight/volume % trisodium citrate as an anticoagulant component and/or an antibacterial component and 15.0 to 25.0 volume/volume % ethyl alcohol as an antibacterial component. Use of the catheter locking solution and catheter locking therapy can reduce treatment failure during medical procedures that may employ catheters to supply treatment by at least significantly reducing the risks associated with bloodstream infections, catheter system malfunction, emboli formation, patient discomfort, and patient illness. These benefits can be partially due to the synergistic antibacterial effects of the trisodium citrate and ethyl alcohol in solution, generating an effective catheter locking solution with minimal concentrations of ethyl alcohol.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: March 9, 2021
    Assignee: Medical Components, Inc.
    Inventors: Premkumar Babu, Benjamin R. Brozanski, Lisa Pagano, Jeffrey S. Bennett
  • Publication number: 20170232153
    Abstract: Various embodiments relate to catheter locking solutions and catheter locking therapies with use of trisodium citrate and ethyl alcohol, and in particular 4.0 to 15.0 weight/volume % trisodium citrate as an anticoagulant component and/or an antibacterial component and 15.0 to 25.0 volume/volume % ethyl alcohol as an antibacterial component. Use of the catheter locking solution and catheter locking therapy can reduce treatment failure during medical procedures that may employ catheters to supply treatment by at least significantly reducing the risks associated with bloodstream infections, catheter system malfunction, emboli formation, patient discomfort, and patient illness. These benefits can be partially due to the synergistic antibacterial effects of the trisodium citrate and ethyl alcohol in solution, generating an effective catheter locking solution with minimal concentrations of ethyl alcohol.
    Type: Application
    Filed: February 6, 2017
    Publication date: August 17, 2017
    Inventors: Premkumar Babu, Benjamin R. Brozanski, Lisa Pagano, Jeffrey S. Bennett
  • Patent number: D905853
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: December 22, 2020
    Assignee: Medical Components, Inc.
    Inventors: Benjamin R. Brozanski, Mark S. Fisher